Search

Search Constraints

You searched for: Author/Creator Pasternak, Amy

Search Results

1. Clinical Variability in Spinal Muscular Atrophy Type III. Issue 6 (2nd October 2020)

2. Different trajectories in upper limb and gross motor function in spinal muscular atrophy. Issue 5 (9th August 2021)

3. DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG. (4th December 2020)

5. EXTH-47. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG. (11th November 2019)

6. HGG-04. USE OF AN ADVANCED RNA-SEQ FUSION PIPELINE RESULTS IN THE TARGETED TREATMENT AND SUSTAINED CLINICAL RESPONSE OF CHILDREN WITH RECURRENT PEDIATRIC HIGH-GRADE GLIOMA. (23rd April 2019)

7. Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease status. Issue 12 (December 2016)

8. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations. Issue 8 (26th February 2019)

9. Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy. Issue 4 (27th July 2019)

10. Nusinersen in pediatric and adult patients with type III spinal muscular atrophy. Issue 8 (24th June 2021)